Eligibility Criteria Studies were eligible if they evaluated BPC-157, thymosin beta-4 or marketed derivatives (including TB-500), GHK-Cu, or other peptide-based agents commonly promoted for musculoskeletal healing or recovery and reported outcomes relevant to musculoskeletal pathology, orthopaedic surgery, postoperative recovery, or perioperative risk domains
A drug under FDA review is not an approved drug
For cell stimulation, cells were pretreated with various concentrations of GHK-Cu of 1, 5, or 10 M for 18 hours, followed by stimulation with 100 ng/ml LPS for specific time periods
Your SALT
"A naturally occurring delta-EEG-enhancing nonapeptide in urine of sleep-deprived rats." Pflugers Archiv
RELATED EPISODE: M&M 252: Scarring, Fibrosis, Oxidative Stress, and Psilocybin & Aging | Louise Hecker Listen or watch on your favorite platform: Support M&M: Visit the SUPPORT PAGE if you find value in this content